{
  "id": 2585,
  "text": "Ann Surg Oncol 23, 2959-2965 (2016).370.Atri, M., et al.Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.Gynecol Oncol 142, 413-419 (2016).",
  "ChatGPT_query": "Please create a <question> that closely aligns with the provided <text>. Ensure that the <question> is formulated in Chinese and does not explicitly reference the text. You may incorporate specific scenarios or contexts in the <question>, allowing the <text> to serve as a comprehensive and precise answer.\n\n<text>: Ann Surg Oncol 23, 2959-2965 (2016).370.Atri, M., et al.Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.Gynecol Oncol 142, 413-419 (2016).\n\n<question>: \n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n",
  "ChatGPT_response_0": "PET-CT在评估晚期宫颈癌患者腹膜后淋巴结转移中的作用和效果方面具有显著的临床价值。首先，PET-CT能够提供高分辨率的影像，帮助医生识别淋巴结是否存在异常代谢活动。特别是在晚期宫颈癌病例中，腹膜后淋巴结转移是评估疾病进展的重要指标。通过检测这些淋巴结的活动情况，PET-CT可以帮助判断癌症是否已经扩散，这对于制定合适的治疗方案至关重要。\n\n其次，PET-CT能够提供准确的解剖定位，使得腹膜后转移的确定更加可靠。这不仅提高了诊断的准确性，还减少了误诊的可能性，有助于提高患者的生存率与生活质量。\n\n最后，PET-CT作为一种非侵入性的检查方法，相较于传统的方法具有更少的风险性和较高的患者接受度。因此，在晚期宫颈癌的评估中，PET-CT是不可或缺的工具。通过这种先进技术，医护人员能够更有效地跟踪疾病的进展，并调整治疗策略。",
  "query": "PET-CT在评估晚期宫颈癌患者腹膜后淋巴结转移中的作用和效果是什么？",
  "ChatGPT_query_a": "You are HuatuoGPT-II, equipped with in-depth knowledge in medicine. Your task is to directly answer the user's <question> in Chinese. In formulating your response, you must thoughtfully reference the <reference text>, ensuring that your reply does not disclose your reliance on <reference text>. Aim to provide a comprehensive and informative response, incorporating relevant insights from <reference text> to best assist the user. Please be cautious to avoid including any content that might raise ethical concerns.\n\n<question>: PET-CT在评估晚期宫颈癌患者腹膜后淋巴结转移中的作用和效果是什么？\n\n<reference text>: Ann Surg Oncol 23, 2959-2965 (2016).370.Atri, M., et al.Utility of PET-CT to evaluate retroperitoneal lymph node metastasis in advanced cervical cancer: Results of ACRIN6671/GOG0233 trial.Gynecol Oncol 142, 413-419 (2016).\n\n**如果text中内容跟宫颈癌无关，请回复'SKIP'**\n\n<reply>: ",
  "response": "PET-CT在评估晚期宫颈癌患者腹膜后淋巴结转移中的作用和效果方面具有显著的临床价值。首先，PET-CT能够提供高分辨率的影像，帮助医生识别淋巴结是否存在异常代谢活动。特别是在晚期宫颈癌病例中，腹膜后淋巴结转移是评估疾病进展的重要指标。通过检测这些淋巴结的活动情况，PET-CT可以帮助判断癌症是否已经扩散，这对于制定合适的治疗方案至关重要。\n\n其次，PET-CT能够提供准确的解剖定位，使得腹膜后转移的确定更加可靠。这不仅提高了诊断的准确性，还减少了误诊的可能性，有助于提高患者的生存率与生活质量。\n\n最后，PET-CT作为一种非侵入性的检查方法，相较于传统的方法具有更少的风险性和较高的患者接受度。因此，在晚期宫颈癌的评估中，PET-CT是不可或缺的工具。通过这种先进技术，医护人员能够更有效地跟踪疾病的进展，并调整治疗策略。"
}